Mindset Pharma Selects Treatment-Resistant Depression and End of Life Cancer Angst as Indications for MSP-1014, its NoveHow Will The Data Protection Ruling On Ketamine Impact Psychedelic Novel Drug Development Moving Forward?Mindset Pharma Announces its Next Generation Novel 5-MeO-DMT Psychedelic AnalogsSilo Pharma Advances Psychedelic Patent PortfolioTryp Therapeutics Completes Psychotherapy Training for Phase 2a Study at the University of FloridaMajor Psychedelic Clinical Trial Data Is Right Around The CornerPsychedelic Drug Development Companies Are Leveraging Bolt On MedTech Acquisitions To Create A More Robust Patient Care 7 Psychedelic Clinical Trials Underway That Investors Should Keep On Their RadarNuminus Wellness Closes Q3 2021 With $63.2 Million Cash Position, Lab and Trial Advances, and Strategic Expansion into PSilo Pharma Awarded Notice of Allowance from United States Patent and Trademark Office for Homing Peptide PatentTryp Therapeutics Announces Q3 2021 Financial ResultsKetamine One’s IRP Clinic Using Innovative NeuroCatch Platform to Measure Brain Function in Injured VeteransWake Network, Inc. and the Lieber Institute for Brain Development Announce Research CollaborationTryp Therapeutics Announces Plans for Phase 2a Clinical Trial for Fibromyalgia with the University of MichiganNuminus Wellness Reaches Major Milestone With MAPS Sponsored MDMA StudyNuminus Announces Health Canada Approval of MAPS-Sponsored Open Label Study for MDMA-Assisted Therapy for PTSDPsyence Group and UK Psychedelic CRO Partners to Conduct UK Palliative Care Clinical TrialTryp Therapeutics Partners with the University of Michigan to Evaluate Proprietary FormulationsPsyched Wellness Commences Next Pre-Clinical Study on AME-1Atai Life Sciences Is Setting The Standard For Psychedelic Drug Development

Technical420 Site Search

Returned 8 result(s).

The Psychedelic Legalization Movement Is In Full Bloom

During the last year, we have seen an increase in the number of governments that are easing regulations against the psychedelic market. Most notably, major cities in California, Colorado and Oregon, have decriminalized psilocybin and this is a development that our readers need to be aware of. The easing of…

Will Psychedelics Take The Same Trip Down The Road To Legalization As The Cannabis Industry?

During the last year, we have seen an increase in the number of governments that are easing regulations against the psychedelic market. Most notably, major cities in California, Colorado and Oregon, have decriminalized psilocybin and this is a development that our readers need to be aware of. The easing of…

MAPS Is Leading The Pack In MDMA Assisted Psychotherapy For The Treatment of PTSD

So far this year, the psychedelic therapy market has been generating significant traction and this is a vertical that our readers need to be aware of. Today, we want to highlight a leading non-profit company that is focused on this vertical and believe that our readers should be aware of…

Atai Life Sciences Is Betting BIG On The Shift In Psychedelics To Treat Mental Illness

2020 has been a tough year for global markets and this is a trend that we have been closely following. During the last year, we have seen a rapid increase in the number of companies that are in the psychedelic market and this is a vertical that we have become…

Join Us At The FUTURE OF PSYCHEDELICS – An Interactive Virtual Conference With The Top Minds In Psychedelics

During the last year, we have seen a paradigm shift with investors who have become highly focused on the psychedelics market and this is a trend that our readers need to be aware of. So far this year, the psychedelic sector has recorded significant advancements, and this is a trend…

Mind Medicine Inc. Is A Compelling Way To Play The Emerging Psychedelics Sector

One of the most interesting new trends that we have come across is related to the work that is being done to develop therapeutic treatments from psychedelic substances to improve health and wellness and the mushroom stocks associated with them. Over the last few years, there has been an increasing…

Revive Therapeutics Announces Filing of FDA Pre-IND Meeting

Revive Therapeutics Ltd. (CSE: RVV), a life sciences company focused on the research and development of therapeutics for infectious diseases and rare disorders, announced today that it has filed its Pre-Investigational New Drug (“pre-IND”) meeting request with the U.S. Food and Drug Administration (“FDA”) for Bucillamine in the treatment of…

Champignon Brands Spotlighted in Publication Discussing Potential of Mushrooms in Medicine

 Champignon Brands Inc. (SHRMF) (SHRM.CN) today announces its placement in an editorial published by NetworkNewsWire, one of 40+ brands in the InvestorBrandNetwork (“IBN”), a multifaceted financial news and publishing company for private and public entities. To view the full publication, “Medical Mushroom Companies Expand as People Seek New Mental Health Treatments,” visit: http://nnw.fm/0H0Mq. The…

Search Again

The psychedelics sector is starting to take off as smart money begins to position itself across the industry.

Stay updated with all latest updates,upcoming events & much more.
Subscribe
SUBSCRIBE NOW
close-link